U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
164071164071Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive DisorderCompletedNo Results AvailableMajor Depressive DisorderDrug: agomelatine|Drug: placebohttps://ClinicalTrials.gov/show/NCT00411099
164072164072Rituximab and GM-CSF in Treating Patients With Newly Diagnosed Follicular B-Cell LymphomaActive, not recruitingNo Results AvailableLymphomaBiological: Rituximab|Biological: Sargramostim (GM-CSF)https://ClinicalTrials.gov/show/NCT00411086
164073164073Study Of The Effects Of SB 480848 (Darapladib) On The Electrical Conduction Of The HeartCompletedNo Results AvailableAtherosclerosisDrug: Darapladibhttps://ClinicalTrials.gov/show/NCT00411073
164074164074Clinical Orthopaedic Data Bank (Acute and Chronic)RecruitingNo Results AvailableOsteoarthritis|Osteosarcoma|Scoliosis|Cerebral Palsyhttps://ClinicalTrials.gov/show/NCT00411060
164075164075Gefitinib in Treating Patients With Previously Untreated Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNo Results AvailableLung CancerDrug: gefitinibhttps://ClinicalTrials.gov/show/NCT00411047
164076164076A Repeated-Dose Evaluation of Use of a Pain Relieving Drug and Safety of OROS Hydromorphone HCI in Patients With Chronic Cancer PainCompletedNo Results AvailableAnalgesics, Opioid|PainDrug: OROS Hydromorphone HCIhttps://ClinicalTrials.gov/show/NCT00411034
164077164077Endometrial Sampling (Pipelle)in IVF PatientsRecruitingNo Results AvailableInfertilityProcedure: Pipelle (Endometrial Sampling)https://ClinicalTrials.gov/show/NCT00411021
164078164078Effects of Naproxen on Physical PerformanceTerminatedNo Results AvailableHealthyDrug: Naproxenhttps://ClinicalTrials.gov/show/NCT00410995
164079164079Gemcitabine Plus Busulfan, Melphalan and Hematopoietic Cell Transplant for Advanced Lymphoid MalignanciesCompletedNo Results AvailableLeukemia|Lymphoma|MyelomaDrug: Busulfan|Drug: Gemcitabine|Drug: Melphalan|Other: Hematopoietic Cell Transplantation|Drug: Rituximab for Patients with B-Cell Malignancies|Drug: Paliferminhttps://ClinicalTrials.gov/show/NCT00410982
164080164080Pilot Clinical Study of the LRS ThermoSuitâ„¢ System in Post Arrest PatientsCompletedNo Results AvailableHeart Arrest|ComaDevice: ThermoSuit(R) Systemhttps://ClinicalTrials.gov/show/NCT00410969
164081164081Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by SurgeryActive, not recruitingNo Results AvailableLiver CancerBiological: bevacizumab|Drug: dexamethasone|Drug: floxuridine|Genetic: protein expression analysis|Other: flow cytometry|Other: immunoenzyme technique|Other: immunohistochemistry staining method|Other: immunologic technique|Other: laboratory biomarker analysis|Procedure: dynamic contrast-enhanced magnetic resonance imaginghttps://ClinicalTrials.gov/show/NCT00410956
164082164082Study of the Effectiveness and Tolerability of OROS Hydromorphone HCI SR(Slow-release) Tablets and Immediate-Release Hydromorphone Tablets in Patients With Chronic PainCompletedNo Results AvailablePainDrug: OROS Hydromorphone HCI SR (slow release)https://ClinicalTrials.gov/show/NCT00410943
164083164083Efficacy and Safety of Subcutaneous Immunotherapy in Birch Pollen Allergic PatientsTerminatedNo Results AvailableAllergyBiological: Subcutaneous immunotherapy - Recombinant birch pollenhttps://ClinicalTrials.gov/show/NCT00410930
164084164084AZD2171 and Pemetrexed Disodium in Treating Patients With Relapsed Non-Small Cell Lung CancerCompletedHas ResultsRecurrent Non-small Cell Lung CancerDrug: cediranib maleate|Drug: pemetrexed disodiumhttps://ClinicalTrials.gov/show/NCT00410904
164085164085Topical Antibiotics and Intravitreous InjectionsCompletedHas ResultsIntravitreous|InjectionsDrug: gatifloxacinhttps://ClinicalTrials.gov/show/NCT00410891
164086164086A Repeated Dose Study of the Metabolism and Action Evaluation of OROS Hydromorphone HCI (Slow Release) Tablets in Patients With Chronic PainCompletedNo Results AvailablePain|Analgesics, Opioid.Drug: OROS Hydromorphone HCI (slow release)https://ClinicalTrials.gov/show/NCT00410878
164087164087Wild Type p53 Adenovirus for Oral PremalignanciesTerminatedNo Results AvailableMouth CancerGenetic: INGN 201https://ClinicalTrials.gov/show/NCT00410865
164088164088Efficacy and Safety of Three Insulin Protocols in Medical Intensive Care Unit PatientsCompletedNo Results AvailableIntensive CareProcedure: Computer-assisted IV insulin infusion protocol (algorithm A)|Procedure: Leuven Strict glycemic control protocol (Algorithm B)|Procedure: Conventional Intermittent Insulin Protocol (Algorithm C)https://ClinicalTrials.gov/show/NCT00410852
164089164089Studies of the Prevention of Atrial Fibrillation by ALAActive, not recruitingNo Results AvailableAtrial Fibrillation|Diet TherapyProcedure: ALA rich diethttps://ClinicalTrials.gov/show/NCT00410839
164090164090Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck CancerCompletedHas ResultsStage III Squamous Cell Carcinoma of the Hypopharynx|Stage III Squamous Cell Carcinoma of the Larynx|Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage III Squamous Cell Carcinoma of the Nasopharynx|Stage III Squamous Cell Carcinoma of theDrug: erlotinib hydrochloride|Drug: cisplatin|Radiation: 3-dimensional conformal radiation therapy|Radiation: intensity-modulated radiation therapy|Procedure: quality-of-life assessmenthttps://ClinicalTrials.gov/show/NCT00410826
164091164091S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the BoneActive, not recruitingNo Results AvailableBreast Cancer|Metastatic CancerDrug: dasatinibhttps://ClinicalTrials.gov/show/NCT00410813
164092164092Insulin Secretory Defects in Pima Indians at High Risk for NIDDMCompletedNo Results AvailableNIDDMhttps://ClinicalTrials.gov/show/NCT00410800
164093164093Safety and Tolerability of Long-term Administration of OROS Hydromorphone HCI (Slow Release) in Cancer PainCompletedNo Results AvailableAnalgesics, Opioid|PainDrug: OROS hydromorphone HCI (slow release)https://ClinicalTrials.gov/show/NCT00410787
164094164094Gemcitabine and Bevacizumab in Treating Patients With Pancreatic Cancer That Has Been Completely Removed By SurgeryTerminatedNo Results AvailablePancreatic CancerBiological: bevacizumab|Drug: gemcitabine hydrochloride|Procedure: adjuvant therapyhttps://ClinicalTrials.gov/show/NCT00410774
164095164095An Efficacy Study Comparing ZD6474 to Placebo in Medullary Thyroid CancerActive, not recruitingHas ResultsThyroid CancerDrug: ZD6474 (Vandetanib)https://ClinicalTrials.gov/show/NCT00410761
164096164096Safety and Tolerability of Long-Term Administration of Hydromorphone HCI CR (Controlled Release)CompletedNo Results AvailablePain|Analgesics, OpioidDrug: OROS hydromorphone HCI CRhttps://ClinicalTrials.gov/show/NCT00410748
164097164097Study of ONO-1078 in Patients With Chronic SinusitisCompletedNo Results AvailableChronic SinusitisDrug: Placebo|Drug: Pranlukast hydratehttps://ClinicalTrials.gov/show/NCT00410735
164098164098Effect of Nuts vs. a Wheat Bran Muffin in Type 2 DiabetesActive, not recruitingNo Results AvailableType 2 Diabetes|Cardiovascular Disease|Diet TherapyDietary Supplement: Whole wheat and bran muffin|Dietary Supplement: Mixed tree nutshttps://ClinicalTrials.gov/show/NCT00410722
164099164099A Pharmacokinetic (PK) Study of NatrOVA Topical Creme (1%) in Pediatric Subjects 6 to 24 Months of AgeCompletedNo Results AvailablePediculosis Capitis (Head Lice)Drug: NatrOVA Creme Rinse (1%)https://ClinicalTrials.gov/show/NCT00410709
164100164100Pegfilgrastim Versus Filgrastim After High-dose ChemotherapyCompletedNo Results AvailableHematological Neoplasms|TumorsDrug: Filgrastim|Drug: Pegfilgrastimhttps://ClinicalTrials.gov/show/NCT00410696

* Görseller ve İçerik tekif hakkına sahip olabilir